Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine

Kevin J Kramer; Erin M Wilfong; Kelsey Voss; Sierra Barone; Andrea R Shiakolas; Nagarajan Raju; Caroline E Roe; Naveenchandra Suryadevara; Lauren M Walker; Steven C Wall; Ariana Paulo; Samuel Schaefer; Debolanle Dahunsi; Camille S. Westlake; James E. Crowe; Robert H Carnahan Jr.; Jeffrey C Rathmell; Rachel H Bonami; Ivelin S Georgiev; Jonathan Michael Irish.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-453981

Documentos relacionados

  1. Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine.
  2. Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine.
  3. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.
  4. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
  5. Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses.
  6. Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection.
  7. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
  8. Multimodal single-cell datasets characterize antigen-specific CD8<sup>+</sup> T cells across SARS-CoV-2 vaccination and infection.
  9. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
  10. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.